Mr.terry Chew
Chief Medical Officer
Prescient Therapeutics
Australia
Biography
Hematologist/oncologist with 20 years experience in biotech & pharma 5 New Drug Applications including DaunoXome, Taxotere and DepoCyte PTX is only 1 of only 2 ASX biotechs with a CMO that has successfully approved drugs
Research Interest
Hematology
